Effect of dexamethasone on binding activity of transcription factors nuclear factor-κB and activator protein-1 in SW982 human synovial sarcoma cells

  • Taisuke Yamazaki
  • Takashi Tukiyama
  • Takayoshi Tokiwa
Reports

Summary

Previously, we showed that dexamethasone (DEX) inhibited the expression of inflammatory cytokines, matrix metalloproteinase-1, and cyclooxygenase-2 messenger ribonucleic acid in SW982 cells. In this study, the effect of DEX on the transcription factors nuclear factor-κB (NF-κB) and activator protein-1 (AP-1) was examined in SW982 cells by electrophoretic mobility shift assay (EMSA). Both NF-κB and AP-1 deoxyribonucleic acid binding activities were detectable in SW982 cells by EMSA, and they were induced by interleukin-1β treatment. DEX inhibited NF-κB binding activity at 10 μM as well as at 100 μM, although the inhibition was only partial. However, DEX had little effect on AP-1 activity. These results suggest that DEX reduces the expression of inflammatory cytokines and other proteins in SW982 cells by inhibiting NF-κB.

Key words

cell line anti-inflammatory agent transcription DNA binding assay 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Auphan, N.; DiDonato, J. A.; Rossette, C.; Helmberg, A.; Karin, M. Immunosupression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286–290; 1995.PubMedCrossRefGoogle Scholar
  2. Bondeson, J.; Brennan, F. M.; Foxwell, B. M. J.; Feldmann, M. Effective adenoviral transfer of IκBa into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-κB dependent. J. Rheumatol. 27:2078–2089; 2000.PubMedGoogle Scholar
  3. Crofford, L. J.; Tan, B.; McCarthy, C. J.; Hla, T. Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum. 40:226–236; 1997.PubMedCrossRefGoogle Scholar
  4. Fini, M. E.; Cook, J. R.; Mohan, R.; Brinckerhoff, C. E. Regulation of matrix metalloproteinase gene expression. In: Parks, W. C.; Mecham, W. C., ed. Matrix metalloproteinase. San Diego, CA: Academic press; 1998: 299–356.Google Scholar
  5. Fujisawa, K.; Aono, H.; Hasunuma, T.; Yamamoto, K.; Mita, S.; Nishioka, K. Activation of transcription factor NF-κB in human synovial cells in response to tumor necrosis factor A. Arthritis Rheum. 31:197–203; 1996.CrossRefGoogle Scholar
  6. Han, C. W.; Choi, J. H.; Kim, J. M.; Kim, W. Y.; Lee, K. W.; Oh, G. T. Glucocorticoid-mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear factor-kappaB activation induced by tumor necrosis factor alpha. Rheumatology 40:267–273; 2001.PubMedCrossRefGoogle Scholar
  7. Kopp, E.; Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956–959; 1994.PubMedCrossRefGoogle Scholar
  8. Lehmann, T.; Murphy, C.; Zahra, D.; Handel, M. L. Reduction of tumor necrosis factor induced nuclear factor-κB nuclear translocation and DNA binding by dexamethasone in human osteoarthritic synovial tissue explants. J. Rheumatol. 29:787–795; 2002.PubMedGoogle Scholar
  9. Lipsky, P. E. Rheumatoid arthritis. In: Issel bacher, K. J., ed. Harrisons principles of internal medicine. New York: McGraw Hill; 1994:1648–1655.Google Scholar
  10. Matsumura, M.; Kakishita, H.; Suzuki, M.; Banba, M.; Hatori, Y. Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells. Life Sci. 69:1067–1077; 2001.PubMedCrossRefGoogle Scholar
  11. Mukaida, N.; Morita, M.; Ishikawa, Y.; Rice, N.; Okamoto, S.; Kasahara, T.; Matsushima, K. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269:13289–13295; 1994.PubMedGoogle Scholar
  12. Oshima, H.; Simons, S. S., Jr. Modulation of glucocorticoid induction of tyrosine aminotransferase gene expression by variations in cell density. Endocrinology 130:2106–2112; 1992.PubMedCrossRefGoogle Scholar
  13. Sakane, T.; Suzuki, N.; Hirose, N., et al. Mechanisms of KE-298, 2-acetyl-thiomethyl-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis. J. Rheumatol. 24:2213–2220; 1997.PubMedGoogle Scholar
  14. Scheinman, R. I.; Gualberto, A.; Jewell, C. M.; Cidlowski, J. A.; Baldwin, A. S. J. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptor. Mol. Cell Biol. 15:943–958; 1995.PubMedGoogle Scholar
  15. Yamazaki, T.; Yokoyama, T.; Akatsu, H.; Tsukiyama, T.; Tokiwa, T. Phenotypic characterization of a human synovial cell line, and its response to dexamethasone. In Vitro Cell. Dev. Biol. 39A:337–339; 2003.CrossRefGoogle Scholar
  16. Yang, J. P.; Merin, J. P.; Nakano, T. Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro. FEBS Lett. 361:89–96; 1995.PubMedCrossRefGoogle Scholar

Copyright information

© Society for In Vitro Biology 2005

Authors and Affiliations

  • Taisuke Yamazaki
    • 1
  • Takashi Tukiyama
    • 1
  • Takayoshi Tokiwa
    • 1
  1. 1.Kohno Clinical Medicine Research InstituteTokyoJapan

Personalised recommendations